Actos is a medication in the class of drugs known as thiazolidinediones (TZD) which help those with Type 2 diabetes regulate glucose levels. Although exercise and a healthy diet can help regulate blood sugar, medication is sometimes the only way some are able to control their diabetes.
Approved by the U.S. Food and Drug Administration (FDA) in 1999, Actos (pioglitazone hydrochloride), manufactured by Takeda Pharmaceuticals, has been tied to serious side effects including, bladder cancer, congestive heart failure, and bone fractures. Adverse event reports received by the FDA prompted the federal agency to order a 10 year safety review of the medication. Meanwhile, adverse events have also prompted litigation as Takeda continues to be named in a growing number of Actos lawsuits filed nationwide.